Turn Therapeutics logo
Turn Therapeutics
TTRX | NASDAQ
Chart Builder DCF Calculator
$8.55
-$0.79 (-8.51%)
At close: Nov 16, 2026, 4:00 PM ET
$8.48
-$0.07 (-0.82%)
After-hours: Nov 16, 2026, 4:43 PM ET

Turn Therapeutics Company Profile

Company profile explained

Company Profile

Turn Therapeutics Inc., officially known as Global Health Solutions, Inc., is a pharmaceutical enterprise dedicated to developing treatments for conditions affecting the skin, nails, and eyes. The company utilizes a proprietary drug delivery system engineered to effectively permeate skin and nail tissues. This advanced technology is integrated into their solutions for both acute and chronic wound care, specifically designed to help combat antibiotic resistance. Consequently, these products empower healthcare institutions to effectively manage a broad spectrum of dermatological challenges, encompassing everything from sudden injuries and persistent wounds to general skin ailments and specific dermatoses. Global Health Solutions, Inc. was established in 2015 and maintains its headquarters in Westlake Village, California.

Key Executives

Name Position
Bradley E. Burnam Founder, Chief Executive Officer & Director
Zuraiz Chaudhary Interim Chief Financial Officer, Vice President of Finance & Chief Accounting Officer
Mohammed Zubair Controller
Neilesh Shailesh Ghodadra Chief Medical Officer & Director
Robert R. Redfield Chief Scientific Officer
Stephen Hahn FASTRO Executive Clinical & Regulatory Lead

Latest SEC Filings

Date Type Title
Oct 19, 2026 ARS Filing
Oct 19, 2026 DEF 14A Filing
Oct 07, 2026 8-K Current Report
Sep 10, 2026 8-K Current Report
Sep 09, 2026 8-K Current Report
Aug 26, 2026 D Filing
Aug 18, 2026 8-K Current Report
Aug 17, 2026 8-K Current Report
Aug 12, 2026 10-Q Quarterly Report
Aug 12, 2026 8-K Current Report
View All SEC Filings ➞
Turn Therapeutics
Turn Therapeutics logo
Country United States
IPO Date Oct 8, 2025
Industry Biotechnology
Sector Healthcare
Employees 2
CEO Bradley E. Burnam

Contact Details

250 N Westlake Blvd Westlake Village, California 91362 United States

Stock Details

Ticker Symbol TTRX
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0002023016
CUSIP Number 90021W105
ISIN Number US90021W1053
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.